Search

Subject immunology -- oncology -- randomized trials

1. Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma. Issue 1 (4th June 2020)

Authors:
Ascierto, Paolo Antonio; Del Vecchio, Michelle; Mackiewicz, Andrzej; Robert, Caroline; Chiarion-Sileni, Vanna; Arance, Ana; Lebbé, Céleste; Svane, Inge Marie; McNeil, Catriona; Rutkowski, Piotr; Loquai, Carmen; Mortier, Laurent; Hamid, Omid; Bastholt, Lars; Dreno, Brigitte; Schadendorf, Dirk; Gar...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • immunology -- oncology -- randomized trials 1